[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kyungpook National University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":112},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,39,65,89],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100613379","fecal-microbiota-transplantation-for-decolonization-of-multidrug-resistant-microorganisms-100613379",false,"NCT07265817","Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms","Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms: Randomized Double Blinded Study","Inclusion Criteria:\n\n* Patients who have positive results in PCR or culture of rectal swab.\n\nExclusion Criteria:\n\n* Not provide a consent.","ALL","19 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.",[26],"Carbapenem-Resistant Enterobacteriaceae Colonization","NOT_YET_RECRUITING","2025-11-24",{"date":30,"type":31},"2025-12-05","ACTUAL",{"date":33,"type":20},"2025-12-01",{"date":35,"type":20},"2027-10-01",{"name":37,"class":38},"Kyungpook National University Hospital","OTHER",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":16,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100211241","analysis-of-biomarkers-from-patients-with-chorioretinal-diseases-100211241","NCT02026843","Analysis of Biomarkers From Patients With Chorioretinal Diseases","Inclusion Criteria:\n\n* age over 20 years\n* patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.\n* patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.\n* control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.\n\nExclusion Criteria:\n\n* under the age of 20 years\n* patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor\n* patients that did not signed the informed consent of the trial\n* patients with intraocular inflammations or infections that requiring any pharmaceutical agent\n* patients with recent ocular trauma",true,"20 Years","80 Years",{"count":49,"type":20},100,"OBSERVATIONAL","This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.",[53,54],"Diabetic Retinopathy","Macular Degeneration","RECRUITING","2025-03-03",{"date":58,"type":31},"2025-03-06",{"date":60,"type":4},"2012-04",{"date":62,"type":20},"2031-04",{"name":37,"class":38},1,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":45,"sex":16,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":4,"studyType":50,"phases":4,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":64},"100532610","the-treatment-effect-for-asymptomatic-common-bile-duct-stone-100532610","NCT06215040","The Treatment Effect for Asymptomatic Common Bile Duct Stone","Multicenter Prospective Study for Efficacy of Asymptomatic Common Bile Duct Stone Treatment","Inclusion Criteria:\n\n* diagnosed as common bile duct stone by image modality examination\n* agreement for this study enrollment\n\nExclusion Criteria:\n\n* no definite common bile duct stone by image modality examination\n* symptomatic patients who complain with fever\u002Fabdominal pain that compatible with common bile duct stone related symptom\n* previously diagnosed as pancreatobiliary malignancy\n* previously treated by endoscopic or percutaneous treatment for bile duct stones\n* severe cardio or pulmonary disease\n* pregnancy or possibility of pregnancy\n* who do not agree with study enrollment","18 Years","85 Years",{"count":75,"type":20},120,"This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.",[78,79,80],"Choledocholithiasis","Asymptomatic Condition","Quality of Life","2024-01-10",{"date":83,"type":31},"2024-01-22",{"date":85,"type":31},"2024-01-02",{"date":87,"type":20},"2028-12-31",{"name":37,"class":38},{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":97,"targetDuration":98,"studyType":50,"phases":4,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":64},"100223991","inflammatory-bowel-disease-registry-in-daegu-gyeongbuk-100223991","NCT02193464","Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk","Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea","EPICODE","Inclusion Criteria:\n\n* Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis\n* Followed up for at least 6 months for the correct diagnosis\n\nExclusion Criteria:\n\n* Patients who do not live in Daegu-Gyeongbuk province",{"count":49,"type":20},"10 Years","The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.",[101],"Idiopathic Chronic Inflammatory Bowel Disease",[103],"inflammatory bowel disease, registry, incidence, Korea","2021-01-08",{"date":106,"type":31},"2021-01-12",{"date":108,"type":31},"2014-09",{"date":110,"type":20},"2026-12",{"name":37,"class":38},""]